HAGERMAN ALLISON (VP, Product Development) purchased 9.5% of their position (10K shares) of ONCOLYTICS BIOTECH INC on the open market
Open‑market purchase worth $8.3K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/13/2026ACC: 0001493152-26-006543
Officer· VP, Product Development
Since Feb 2026
+10K
Net shares
Net buyer
$8.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+10K
Price / share
$0.83
Trade value
$8.30K
% of position
9.5%
2/12/2026
105.06K→115.06K
Total
Net shares
+10K
Net value
$8.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 2/12/2026 | P · Purchase | +10K | $0.83 | $8.30K | 9.5% | 105.06K | 115.06K |
| Total | +10K | $8.30K | ||||||
Derivative Transactions0
No derivative transactions reported